REGENERON PHARMACEUTICALS, INC. Quarterly Current Ratio in % from Q1 2011 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Regeneron Pharmaceuticals, Inc. quarterly Current Ratio history and growth rate from Q1 2011 to Q3 2024.
  • Regeneron Pharmaceuticals, Inc. Current Ratio for the quarter ending September 30, 2024 was 542 %, a 2.57% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 542 +13.6 +2.57% Sep 30, 2024
Q2 2024 539 +6.16 +1.16% Jun 30, 2024
Q1 2024 539 +14.7 +2.8% Mar 31, 2024
Q4 2023 544 +37 +7.3% Dec 31, 2023
Q3 2023 528 +66.8 +14.5% Sep 30, 2023
Q2 2023 533 +112 +26.6% Jun 30, 2023
Q1 2023 525 +139 +36.1% Mar 31, 2023
Q4 2022 507 +156 +44.6% Dec 31, 2022
Q3 2022 461 +110 +31.3% Sep 30, 2022
Q2 2022 421 +68.3 +19.4% Jun 30, 2022
Q1 2022 385 +77.6 +25.2% Mar 31, 2022
Q4 2021 351 +22.8 +6.96% Dec 31, 2021
Q3 2021 351 +24.7 +7.56% Sep 30, 2021
Q2 2021 353 +27.3 +8.38% Jun 30, 2021
Q1 2021 308 -86.7 -22% Mar 31, 2021
Q4 2020 328 -72.6 -18.1% Dec 31, 2020
Q3 2020 327 -95.2 -22.6% Sep 30, 2020
Q2 2020 325 -97.8 -23.1% Jun 30, 2020
Q1 2020 394 -24.9 -5.94% Mar 31, 2020
Q4 2019 400 +5.96 +1.51% Dec 31, 2019
Q3 2019 422 +44.9 +11.9% Sep 30, 2019
Q2 2019 423 +57.1 +15.6% Jun 30, 2019
Q1 2019 419 +49.9 +13.5% Mar 31, 2019
Q4 2018 394 +47.5 +13.7% Dec 31, 2018
Q3 2018 377 +62.3 +19.8% Sep 30, 2018
Q2 2018 366 +53 +16.9% Jun 30, 2018
Q1 2018 369 +65.5 +21.5% Mar 31, 2018
Q4 2017 347 +27.3 +8.53% Dec 31, 2017
Q3 2017 315 -35.5 -10.1% Sep 30, 2017
Q2 2017 313 -36.2 -10.4% Jun 30, 2017
Q1 2017 304 -55 -15.3% Mar 31, 2017
Q4 2016 320 -59.8 -15.8% Dec 31, 2016
Q3 2016 350 -20 -5.39% Sep 30, 2016
Q2 2016 349 -54 -13.4% Jun 30, 2016
Q1 2016 359 -77.2 -17.7% Mar 31, 2016
Q4 2015 379 -89.6 -19.1% Dec 31, 2015
Q3 2015 370 -200 -35.1% Sep 30, 2015
Q2 2015 403 -187 -31.7% Jun 30, 2015
Q1 2015 436 -202 -31.6% Mar 31, 2015
Q4 2014 469 -181 -27.9% Dec 31, 2014
Q3 2014 570 -115 -16.8% Sep 30, 2014
Q2 2014 590 -86.1 -12.7% Jun 30, 2014
Q1 2014 638 +52.1 +8.9% Mar 31, 2014
Q4 2013 650 +122 +23.2% Dec 31, 2013
Q3 2013 685 +226 +49.1% Sep 30, 2013
Q2 2013 676 +281 +70.9% Jun 30, 2013
Q1 2013 586 +219 +59.9% Mar 31, 2013
Q4 2012 528 +199 +60.3% Dec 31, 2012
Q3 2012 459 +167 +56.9% Sep 30, 2012
Q2 2012 395 +54.9 +16.1% Jun 30, 2012
Q1 2012 366 +13 +3.69% Mar 31, 2012
Q4 2011 329 Dec 31, 2011
Q3 2011 293 Sep 30, 2011
Q2 2011 341 Jun 30, 2011
Q1 2011 353 Mar 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.